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The polytopic inner membrane protein MalF is a constituent
of the MalFGK2 maltose transport complex in Escherichia coli.
We have studied the biogenesis of MalF using a combination of
in vivo and in vitro approaches. MalF is targeted via the SRP
pathway to the Sec/YidC insertion site. Despite close proximity
of nascent MalF to YidC during insertion, YidC is not required
for the insertion of MalF into the membrane. However, YidC is
required for the stability of MalF and the formation of the
MalFGK2 maltose transport complex. Our data indicate that
YidC supports the folding of MalF into a stable conformation
before it is incorporated into the maltose transport complex.
In the Gram-negative bacterium Escherichia coli, different
inner membrane protein targeting and insertion pathways are
operational (1). Although the biogenesis requirements of only a
few membrane proteins have been studied thoroughly, most of
them are targeted via the signal recognition particle (SRP)5
pathway to the innermembrane where they are delivered at the
Sec translocon (2, 3). The core of the Sec translocon consists of
the integral membrane proteins SecY and SecE and the periph-
eral ATPase SecA (4–6). SecY and -E form a protein-conduct-
ing channel that canmediate both translocation andmembrane
insertion (4, 7). It has been proposed that the translocon chan-
nel can open laterally toward the lipid bilayer thereby allowing
the release of transmembrane segments (TMs) into the mem-
brane (6, 8). The ATPase SecA is required for the translocation
of large (60 amino acids) periplasmic domains of inner mem-
brane proteins (1, 9).
The inner membrane protein YidC, which is essential for
viability, has been identified as a factor that assists in the inte-
gration, folding, and assembly of inner membrane proteins
both in association with the Sec translocon and separately (10,
11). Thus far, only a handful of inner membrane proteins that
insert via the YidC-only pathway have been identified. All these
proteins are small and do not contain a sizable periplasmic
domains and more than two TMs. It is not clear how YidC
assists the biogenesis of these proteins. During the biogenesis of
SRP/Sec translocon-dependent inner membrane proteins,
YidC specifically interacts with the TMs of these proteins (e.g.
Refs. 12–15). It has been suggested that YidC mediates the
transfer of TMs from the Sec translocon into the lipid bilayer
(1). Indeed, YidC could be co-purified with the Sec translocon,
suggesting a physical connection (14). A recent in vitro study
using lactose permease (LacY) reveals a novel function for YidC
in the co-translational folding of this inner membrane protein
rather than its insertion into the membrane (16). The observa-
tion that YidC depletion leads to the induction of the Cpx and
E envelope stress responses, which both sense protein mis-
folding in the cell envelope, also points to a role of YidC in the
folding of inner membrane proteins (17, 18).
Here, we have used the inner membrane protein MalF as a
model protein to study the role of YidC in the biogenesis of
polytopic innermembrane proteins, which are part of a hetero-
oligomeric complex. MalF functions in maltose transport as a
1:1:2 complex with the integral inner membrane protein MalG
and the peripheral inner membrane proteinMalK (19, 20). The
complex belongs to the ATP-binding cassette (ABC) trans-
porter superfamily. MalF is a 514-amino acid-long inner mem-
brane protein containing 8TMs,with itsN andC termini facing
the cytosol (21) (see Fig. 1). A large periplasmic domain (180
amino acids) is present between the third and the fourth trans-
membrane segments. This domain folds into a trypsin-resistant
conformation when MalF is incorporated into the MalFGK2
maltose transport complex (22).
The biogenesis ofMalFwas studied using a combination of in
vivo and in vitro approaches. MalF was found to be targeted via
the SRP pathway to the Sec/YidC insertion site. Despite close
proximity of nascent MalF to YidC during insertion, YidC
appeared dispensable for the insertion of MalF into the mem-
brane. However, YidC is required for the stability of MalF and
the formation of the MalFGK2 maltose transport complex sug-
gesting an important role of YidC in the assembly of oligomeric
complexes in the inner membrane.
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EXPERIMENTAL PROCEDURES
Materials—Restriction endonucleases and the Expand Long
Template PCR system were from Roche Molecular Biochemi-
cals. The Megashort Script T7 transcription kit was from
Ambion Inc. [35S]Methionine and protein A-Sepharose were
both from GE Healthcare. T4 ligase and T4 DNA polymerase
were both from Epicenter Technologies. n-Dodecyl--D-mal-
topyranoside was from Anatrace. Serva Blue G was obtained
from Serva. All other chemicals were obtained from Sigma. A
polyclonal antibody against the c-Myc epitope tagwas obtained
from Abcam. Antisera against SecY, SecE, YidC, and Ffh were
from our own collection. Antisera against MalF, -G, and -K,
trigger factor (TF), and L23 were kind gifts from A. Davidson,
W. Wickner, and R. Brimacombe, respectively.
In Vitro Cross-linking—E. coli strain MRE600 was used to
prepare a lysate for translation of in vitro synthesized mRNA
and suppression of UAG stop codons in the presence of (Tmd)-
Phe-tRNAsup. Strain MC4100 was used to isolate inverted
membrane vesicles (IMVs). Strain JM110 was used to isolate
pC4Meth-derived plasmids for in vitro transcription.
pC4Meth-derived plasmids for in vitro expression of trun-
cated forms of MalF were constructed by PCR using pTAZFQ
as template (23). These plasmids encode truncated MalF fused
to a 4methionine tag to improve labeling efficiency of nascent
chains with [35S]methionine. Immunoprecipitation of nascent
chains was enabled by constructing a complementary set of
constructs with a C-terminal c-Myc epitope tag (EQKLI-
SEEDL) fused to the truncated MalF sequence. Furthermore,
ambermutations (TAG) were introduced at the indicated posi-
tions to enable sup-tRNA photo-cross-linking, as described
previously (14). The nucleotide sequence of all constructs was
confirmed by DNA sequencing.
TruncatedmRNAs were prepared fromHindIII- or ClaI-lin-
earized pC4Meth-derived plasmids. In vitro translation, target-
ing to IMVs, photo-cross-linking, carbonate extraction (to sep-
arate membrane-bound material from non-membrane-bound
material), and sample processing were performed as described
previously (14).
Strains, Plasmids, Growth Conditions, and Assay Used in
MalF Membrane Targeting/Insertion Experiments in Vivo—
The 4.5 S RNA conditional strain FF283 was cultured in M9
minimal medium (for composition, see Ref. 24) supplemented
with 1mM IPTGas described previously (24). To deplete cells of
4.5 S RNA, cells were grown to mid-log phase in the absence of
IPTG. The temperature-sensitive amber suppressor SecA
depletion strain BA13 and the control strain DO251 were cul-
tured in M9 minimal medium at 30 °C, as described previously
(24). To deplete cells of SecA, theywere grown tomid-log phase
at 41 °C. The SecE depletion strain CM124 was cultured in M9
minimal medium supplemented with 0.2% glucose and 0.2%
L-arabinose as described previously (24). To deplete cells of
SecE, cells were grown to mid-log phase in the absence of L-
arabinose.DepletionofSecAandSecEwascheckedbymonitoring
the accumulation of pro-OmpAduring a short pulse-labeling step
with [35S]methionine. The SecG deletion strain KN370 was cul-
tured inM9minimalmedium tomid-log phase, and plasmid pH
was used to complement with SecG as described previously (24).
The YidC depletion strain FTL10 was cultured in M9 minimal
mediumsupplementedwith0.2%glucose and0.2%L-arabinose, as
described previously (25). To deplete cells of YidC, cells were
grown tomid-log phase in the absence of L-arabinose.
MalF was expressed by arabinose induction from the
pBAD24 vector (26) in strains FF283, BA13, DO251, and
KN370 (pH), by IPTG induction from the pEH1 vector (27)
in strain CM124 and by IPTG induction from the pEH3 vector
(27) in strain FTL10. Where appropriate, ampicillin (final con-
centration, 100 g/ml), chloramphenicol (final concentration,
30 g/ml), kanamycin (final concentration, 50 g/ml), strepto-
mycin (final concentration, 25 g/ml), and tetracycline (final
concentration, 12.5 g/ml) were added to the medium.
For all experiments cells were grown to mid-log phase.
Expression of the constructs was induced for 3 min with either
IPTG (final concentration, 1 mM) or L-arabinose (final concen-
tration, 0.2%). Cells were labeled with [35S]methionine (100
Ci/ml, 1 Ci  25 GBq) for 30 s. After labeling, cells were
converted to spheroplasts. For spheroplasting, cells were col-
lected at 14,000 rpm for 30 s in a microfuge, resuspended in
ice-cold buffer (40%w/v sucrose, 33mMTris-HCl, pH 8.0), and
incubated with lysozyme (final concentration, 5 g/ml) and 1
mM EDTA for 15 min on ice. Aliquots of the spheroplast sus-
pension were incubated on ice for 1 h either in the presence or
absence of proteinase K (final concentration, 0.3 mg/ml). Sub-
sequently, phenylmethylsulfonyl fluoride was added to the
spheroplast suspension (final concentration, 0.33 mg/ml) to
inhibit the protease. After addition of phenylmethylsulfonyl
fluoride, samples were precipitated with trichloroacetic acid
(final concentration, 10%), washed with acetone, resuspended
in 10 mM Tris-HCl, pH 8.0/2% SDS, immunoprecipitated with
antisera to MalF, OmpA (a periplasmic control), and AraB/
bandX (a cytoplasmic control), washed, and analyzed by stand-
ard SDS-PAGE (24). Gels were scanned in a Fuji FLA-3000
phosphorimaging device and quantitated using Image Gauge
(version 3.4). All pulse experiments were repeated at least three
times.
For theMalF biotinylation-based membrane insertion assay,
the genes encoding the MalF derivatives MalF I (MalF with a
PBST biotinylation domain engineered in the periplasmic loop
between TM3 and -4, Fig. 1) and MalF L (MalF with a PBST
biotinylation domain engineered in the cytoplasmic loop
between TM4 and -5, Fig. 1) were cloned into the expression
vector pASK-IBA3 (IBA GmbH, Germany) (28). The expres-
sion vectors containing the two derivatives of MalF were trans-
formed into the conditional YidC strain FTL10. Cells were
grown overnight in LBmedium containing arabinose. Cultures
were then washed and transferred into fresh LB medium con-
taining arabinose or glucose to deplete cells for YidC. Expres-
sion of MalF-I and -L was induced by addition of 0.2 g/ml
anhydrotetracycline. After 4 h samples were taken and pro-
cessed for SDS-PAGE and immunoblotting. Biotinylated pro-
teins were detected using streptavidin-horseradish peroxidase
(GE Healthcare).
Analysis of the Accumulation Levels of the MalFGK2Maltose
Transport Complex by Blue Native PAGE—Overnight cultures
of MC4100ara and FTL10 cells were grown in LB medium
supplemented with 0.2% glycerol. To induce the expression of
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YidC in FTL10 during growth overnight, 0.2% arabinose was
added. Cells were harvested by centrifugation and resuspended
to an A660 of 0.05 in fresh LB medium supplemented with 0.2%
glycerol and 0.2% maltose. It should be noted that the maltose
transport complex is also expressed in the absence of maltose
(29). After 3 h of growth, cells were collected by centrifugation
and fractionated, and IMVs were isolated as described before
(29). The accumulation levels of the MalFGK2 maltose trans-
port complexwere analyzed by blue native-PAGE (30) followed
byWestern blot analysis. Sample preparation and running con-
ditions were essentially as described previously (29). For blot-
ting of blue native-PAGE gels, the cathode buffer containing
0.02% Serva Blue Gwas exchanged after one-third of the run to
cathode buffer containing 0.002% Serva Blue G. This was done
to prevent excessive binding of the dye to the polyvinylidene
difluoride membrane. Blotting and decoration of blots with
antisera to MalF, -G, -K, YidC, and SecY were performed as
described previously (29).
WesternBlottingAnalysis—The accumulation levels ofMalF,
MalK,MalG, and YidC in innermembranes weremonitored by
immunoblot analysis. IMVs (3–5g of protein) were separated
by standard SDS-PAGE, and immunoblotting was performed
as described previously (29). To verify the specificity of the
MalG signal, a malG deletion mutant (SW1242) was used (see
below).
Construction of malG and malK Deletion Strains and FTL10
malF::Tn10—malG and malK deletion mutants were made
using the Red Swap method (31). In brief, primers “malG_
ECOLI_swapc_HP1” (5-AACCTGAAAGCCACGCGAATGA-
AGTTTGATTAAGGGAGATAACAAAAATGTGTAGGC-
TGGAGCTGCTTCG-3) and “malG_ECOLI_swapc_HP2”
(5-AGCGGCATAACATTGGCAGAACAACATCTTTAACC-
TTTCACACCACCTGCCATATGAATATCCTCCTTAG-
3) or “malK_ECOLI_swapc_HP1” (5-TCATGAATGTTGCTG-
TCGATGACAGGTTGTTACAAAGGGAGAAGGGCATGT-
GTAGGCTGGAGCTGCTTCG-3) and “malK_ECOLI_swapc_
HP2” (5-TGACAGGCTTTGTGTGTTTTGTGGGGTGCT-
TAAACGCCCGGCTCCTTATGCATATGAATATCCTCCT-
TAG-3)wereused toamplify thechloramphenicol resistancecas-
sette from pKD3 (31). MC4100ara harboring plasmid pKD46
(31) was grown in SOB medium (for composition, see Ref. 31)
supplemented with 100 g/ml ampicillin and 0.2% L-arabinose
and used to make competent cells. After electroporation with the
PCR product, chloramphenicol-resistant colonies were isolated
on agar plates containing 30 g/ml chloramphenicol. Deletion of
malG andmalK was verified by PCR with the following primers:
k1, k2 (31), “malG_ECOLI_swap_U” (5-CAATTGCCACGCT-
GATCTTC-3), “malG_ECOLI_swap_D” (5-CGTGACTCAG-
AGCACGAAAG-3), “malK_ECOLI_swap_U” (5-GGTGGAG-
GATTTAAGCCATC-3), and “malK_ECOLI_swap_D” (5-
GCTACCTGTCCAACCAATAC-3). Strains SW1242 (malG)
andSW1282 (malK)were tested for defectivemaltose fermenta-
tion onMcConkey agar plates containing 1%maltose.
ThemalF::Tn10 (TetR) mutant allele (a kind gift of Michael
Ehrmann, University of Duisburg-Essen, Germany) was moved
into strain FTL10 by bacteriophage P1-mediated generalized
transduction (32). FTL10 malF::Tn10 (TetR) transductants
were selected at 37 °C on LB agar plates supplemented with
sodium citrate (10mM), L-arabinose (0.1%), and tetracycline (15
g/ml). Transductants were further tested for defective malt-
ose fermentation onMcConkey agar plates containingmaltose.
Monitoring the Stability of MalF upon Depletion of YidC—
Overnight cultures of MC4100ara, FTL10, SW1242, and
SW1282 cells were grown in LB medium supplemented with
0.2% glycerol. To induce the expression of YidC in FTL10 dur-
ing growth overnight, 0.2% arabinose was added. Cells were
harvested by centrifugation and resuspended to an A660 of 0.05
in fresh LB medium supplemented with 0.2% glycerol. To
induce the expression of YidC in FTL10, 0.2% arabinose was
added. To induce the expression of the mal operon, 0.2% malt-
ose was added. After 3 h of growth, cells were collected by
centrifugation and resuspended to an A660 of 2.0 in 1 ml of
minimal medium supplemented with all amino acids, except
methionine and cysteine, and containing 0.2% glycerol and
0.2% maltose. Cells were labeled with [35S]methionine for 5
min, followed by chases of 3, 30, and 60 min, and subsequently
precipitated with trichloroacetic acid. Precipitated material
was processed as described above under “Strains, Plasmids,
Growth Conditions, and Assay Used in MalF Membrane Tar-
geting/Insertion Experiments in Vivo.”
RESULTS
Nascent MalF Interacts with TF, Ffh, and the Ribosomal
Component L23 and Inserts into the Inner Membrane in the
Vicinity of YidC and the Sec Translocon—We initially analyzed
the pathway of targeting andmembrane insertion ofMalF using
an in vitro translation/targeting/photo-cross-linking approach.
Radiolabeled nascent MalF of 88 amino acids was synthesized
in a wild-type cell-free E. coli extract in the presence of inverted
inner membrane vesicles to allow membrane targeting and
insertion on the ribosome nascent chain complex (14). At this
length, the ribosome nascent chain complex is expected to fully
expose the first and second TMs of MalF, assuming that the
ribosome covers30 amino acids (33). To enable the incorpo-
ration of a photoreactive probe in the middle of the first TM of
MalF, a single TAGamber codonwas introduced at position 26.
Following translation in the presence of (Tmd)Phe-tRNAsup
and UV-induced cross-linking, samples were extracted with
sodium carbonate at pH 11.5 to separate membrane-integrated
FIGURE 1. Topology ofMalF andMalF derivativesMalF-PBST I and L.MalF
contains eight TMs, and both the N and C termini face the cytosol. A large
periplasmic domain (180 amino acids) is present between the third and the
fourth TMs. In MalF derivative MalF-PBST I the PSBT biotin-accepting domain
from the 1.3 S subunit of P. shermanii transcarboxylase (PSBT) was engineered
in the large periplasmic loop between TM3 and -4, and in theMalF derivative
MalF-PBST L the PBST domain was engineered in the small cytoplasmic loop
between TM4 and i5.
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from untargeted material. Cross-linked partners were identi-
fied by immunoprecipitation with specific antibodies.
The TAG26 mutation in 88MalFTAG26 was efficiently sup-
pressed by (Tmd)Phe-tRNAsup (data not shown), resulting in
nascentMalF of the expectedmolecularweight. 88MalFTAG26
was efficiently targeted to IMVs, as judged by the relative
amount of carbonate-resistantmaterial (Fig. 2, compare lanes 1
and 2). Upon UV irradiation, several specific cross-linking
products could be observed in the carbonate supernatant and
pellet fractions (Fig. 2, lanes 3 and 7). An adduct of 55 kDa
could be immunoprecipitated with antiserum to Ffh, the pro-
tein component of E. coli SRP (Fig. 2, lane 5). Substantial
amounts of smaller adducts were also precipitated with anti-
serum to Ffh, which most probably represent cross-linked deg-
radation products of Ffh (34). A cross-linking product of 65
kDa could be immunoprecipitated with antiserum to trigger
factor (TF), which is a cytosolic chaperone with general affinity
for nascent polypeptides that resides on the ribosome close to
the nascent chain exit site (35, 36) (Fig. 2, lane 4). A prominent
20-kDa cross-link product was precipitated with antibodies
directed toward the ribosomal protein L23 (Fig. 2, lane 6),
which is located near the nascent chain exit site (37). Ffh andTF
have both been shown to associate with L23 (34, 36, 38–40). In
the carbonate pellet fraction a very strong cross-linking prod-
uct of60 kDa becomes apparent after UV irradiation (Fig. 2,
lane 7). We could immunoprecipitate this adduct with anti-
serum to YidC (Fig. 2, lane 8) (35). A less prominent band of
40 kDa could be immunoprecipitated with antiserum to SecY
(Fig. 2, lane 9) (35).
In summary, using this unbiased approach it was shown that,
at a nascent chain length of 88 amino acids, TM1 ofMalF inter-
acts withTF, SRP, and L23 and inserts into the innermembrane
in a carbonate-resistant state close to YidC and SecY. This
strongly suggests that MalF is targeted via the SRP pathway to
the SecY/YidC insertion site in the inner membrane.
TM1 of MalF Remains Close to YidC and the Sec Translocon
during Insertion of TM2 and TM3 of MalF into the Membrane,
and TM2 and TM3 Insert into the Membrane in a Molecular
Environment Similar to That of TM1—To study the sequence
of events taking place during the biogenesis of the three N-ter-
minal TMs of MalF, nascent chains of increasing lengths were
synthesized in vitro. The shortest nascent chain, 68MalF, is
expected to fully expose the first TM segment from the ribo-
some nascent chain complex (see Fig. 3A). At a length of 100
amino acids, 100MalF exposes TM1 and TM2. 131MalF, the
longest nascent chain, exposes TM1, TM2, and TM3. By plac-
ing a TAG codon at position 26 and by exploiting the photo-
cross-linking procedure described above, the molecular envi-
ronment of TM1 in each of these translation intermediates was
studied. C-terminal c-Myc epitope tags were introduced to
enable purification of nascent chains by immunoprecipitation.
Previous work has shown that this approach can prevent mis-
interpretations of cross-linking experiments due to premature
termination of translation (41).
For each of the constructs, the TAG codon was suppressed,
and nascent MalF of the expected apparent molecular weight
was produced (data not shown). As shown in Fig. 3B, all nascent
chains could be immunoprecipitated using the anti-c-Myc anti-
bodies. UponUV irradiation, several adducts were resolved and
co-immunoprecipitated with the nascent chains of desired
length. 68MalFTAG26-Myc cross-linked YidC and SecY (Fig.
3B, lane 1). Also, an adduct of25 kDa was present that could
be precipitatedwith anti-SecE (Fig. 3C, lane 3). As expected, the
100MalFTAG26-Myc nascent chain was cross-linked to YidC
and SecY, similar to 88MalFTAG26 (compare Fig. 2, lane 7 to
Fig. 3B, lane 2), because both constructs expose TM1 and TM2
and share a cross-link site at an identical position. Notably, the
SecE cross-link was lost at this length. These cross-links repre-
sent the molecular environment of TM1 after both TM1 and
TM2 are completely exposed outside the ribosome (Fig. 3A).
Upon further extension of theMalF nascent chain to a length of
131 amino acids, the photoprobe in TM1 continued to cross-
link YidC and SecY, whereas the SecE adduct reappeared (Fig.
3B, lane 4). These results show that TM1 of MalF initially
FIGURE 2. Interactions of nascent 88MalFTAG26. 88MalFTAG26 was syn-
thesized in vitro in the presence of (Tmd)Phe-tRNASup and E. coli wild-type
IMVs. After translation, samples were either kept in the dark (UV) or, alter-
natively, cross-linking was induced by UV irradiation (UV). A carbonate
extractionwas performed to separatemembrane-integrated (p) from soluble
and peripheral membrane proteins (s). Immunoprecipitations were per-
formed using the indicated antibodies. Immunoprecipitated samples and
carbonate pellets and supernatants were subjected to SDS-PAGE and phos-
phorimaging. The position of the 88MalFTAG26 nascent chain in the gel is
indicated. Peptidyl-tRNA band is marked with an asterisk.
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inserts into themembrane in a carbonate resistant formclose to
YidC, SecY, and SecE. At all nascent chain lengths studied here,
the contacts of TM1 with YidC and SecY remain. The SecE
contact is temporarily lost upon extension of the nascent chain,
but reappears at a later stage, when TM1, TM2, and TM3 have
all left the confinement of the ribosome.
The interactions of TM2 were
mapped by establishing the cross-
links of 100MalFTAG47-Myc
and 131MalFTAG47-Myc nascent
chains.With both constructs, cross-
links to YidC, SecY, and SecE were
co-immunoprecipitated with the
nascent chains by anti-C-Myc anti-
body (Fig. 3B, lanes 3 and 5).
131MalFTAG85-Myc was also
cross-linked to YidC, SecY, and
SecE, indicating that the molecular
environment of TM3 at this stage of
biogenesis was comparable to that
of TM1 and TM2 (Fig. 3B, lane 6).
These data indicate that TM2 and
TM3 initially insert into the mem-
brane close to YidC, SecY, and SecE
and therefore behave like TM1.
TM2 also remains close to these
proteins when TM3 has inserted
into the membrane. This indicates
that at least the first three TMs of
MalF assemble simultaneously at
the Sec/YidC insertion site in the
inner membrane and do not parti-
tion completely into the lipids at
this stage in biogenesis.
Efficient Membrane Targeting
and Insertion of MalF Requires SRP
and the Sec Translocon—Next, tar-
geting and insertion of full-length
MalF expressed from a plasmid
were monitored in vivo in SRP and
Sec translocon mutant strains by
analyzing the proteinase K accessi-
bility of MalF in spheroplasts.
OmpA, outer membrane protein A,
served as a positive control for
spheroplast formation by monitor-
ing the proteinase K sensitivity of its
periplasmic domain (42). Band X, a
cytoplasmic protein, is a negative
control. It is used to confirm the
spheroplasts are intact (42).
Depletion of the essential SRP
component 4.5 S RNA compro-
mises the SRP-targeting pathway
(43). Depletion of 4.5 S RNA
strongly inhibited proteolysis of
MalF in spheroplasts, as compared
with spheroplasts made of non-de-
pleted (control) cells (Fig. 4A). Notably, processing of the Sec-
dependent OmpA protein was not affected upon 4.5 S RNA
depletion, which shows that the Sec translocon was functional
under these conditions. Assembly of MalF was further studied
in a SecE depletion strain. Upon depletion of SecE, SecY is rap-
idly degraded by the FtsH protease resulting in the loss of the
FIGURE 3. The molecular environment of MalF TM1, -2, and -3. A, schematic representation of MalF ribo-
some nascent chain complexes. TMs exposed outside the ribosome are dark gray, and TMs buried inside the
ribosomal tunnel are black andwhite. The open circle indicates the position of the cross-linking site. All nascent
chains contain a C-terminal Myc tag (Myc). B, MalFmRNAs containing single UAG codonswere used to synthe-
size the corresponding nascent chains in the presence of (Tmd)Phe-tRNASup and E. coliwild-type IMVs in vitro.
After translation, sampleswere cross-linked byUV irradiation. The pellet fraction of a carbonate extractionwas
subjected to immunoprecipitation with anti-Myc antibodies. Immunoprecipitated samples were subjected to
SDS-PAGEandphosphorimaging. Thepositions in thegel of nascent chains (NCs), and cross-links to YidC, SecY,
and SecE are indicated. C, 68MalFTAG26 was synthesized and UV-cross-linked as described in B. Carbonate
extractionwas used to separatemembrane integrated (p) from soluble and peripheral membrane proteins (s).
Anti-SecE antibodies were used for immunoprecipitation. Samples were further processed as described in B.
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SecY/E core of the translocon (44). Depletion of SecE strongly
inhibited proteolysis ofMalF in spheroplasts, as comparedwith
non-depleted (control) cells (Fig. 4B and Ref. 45). As expected,
processing and translocation of the Sec-dependent OmpA was
strongly affected upon SecE depletion. Upon depletion of SecA,
which does not affect the rest of the Sec translocon (46), prote-
olysis of MalF in spheroplasts was strongly reduced compared
with the control sample (Fig. 4C). This indicates that SecA is
required for the biogenesis, presumably by energizing the
translocation of the periplasmic loop between TM3 and -4.
Processing and translocation of OmpA were, as expected, also
affected upon SecAdepletion. Finally, the insertion ofMalFwas
not affected in the absence of the non-essential Sec translocon
component SecG (Fig. 4D).
Taken together, these data indicate that MalF is targeted to
the inner membrane via the SRP pathway and that insertion of
MalF into the innermembrane is SecAYE-dependent. This is in
keepingwith the in vitro cross-linking data described above and
previous in vivo studies (e.g. Refs. 45, 47, 48).
Insertion of MalF into the Inner Membrane Does Not Depend
on YidC—The close proximity of nascent MalF to YidC during
insertion in the membrane as shown by cross-linking (see Figs.
2 and 3) suggests that YidC plays an important role in the bio-
genesis of MalF. Therefore, insertion of plasmid-expressed
MalF into the inner membrane was monitored in the YidC
depletion strain FTL10 by analyzing the proteinase K accessi-
bility of MalF in spheroplasts (Fig. 4E). Insertion of MalF into
the inner membrane was not affected upon the depletion of
YidC. Cells were efficiently depleted of YidC as determined by
immunoblotting (data not shown), and the translocation of
OmpA was, as expected, not affected upon YidC depletion.
To study the role of YidC in the insertion of MalF into the
inner membrane in vivo in more detail, we used a very sensitive
biotinylation assay (28). TwoMalF derivativeswere engineered,
one containing the Propionibacterium shermanii transcarbox-
ylase (PSBT) biotin-accepting domain from the 1.3 S subunit of
PSBT in the large periplasmic loop betweenTM3 and -4 (MalF-
PBST I), and the other containing the PBSTdomain in the small
cytoplasmic loop between TM4 and -5 (MalF-PBST L) (Fig. 1).
The PSBT domain is biotinylated by the cytoplasmic enzyme
biotin ligase. Hence, to be biotinylated, the PBST domain must
at least temporarily be exposed to the cytoplasm (28). As
expected,MalF-PSBTLwas efficiently biotinylated irrespective
of the presence/depletion of YidC (Fig. 5). MalF-PSBT I was
neither in the presence nor upon the depletion of YidC biotin-
FIGURE 4. Membrane insertion of MalF is SRP/SecAYE-dependent and
YidC-independent. A, proteinase K accessibility of MalF (top) and OmpA/
bandX (bottom) in FF283 (4.5 SRNAdepletion strain) spheroplasts,made from
cells cultured in the presence/absence of IPTG (, non-depleted cells; ,
depleted cells). Cells were pulse-labeled and processed as described under
“Experimental Procedures.” OmpA is only degraded by proteinase K in cells
with a disrupted outer membrane. OmpA secretion/processing was not
affected upon SRP-depletion. band X is a cytoplasmic control and is not
degradedbyproteinaseK in spheroplasts.B, proteinaseKaccessibility ofMalF
(top) and OmpA/bandX (bottom) in CM124 (SecE depletion strain) sphero-
plasts, made from cells cultured in the presence/absence of arabinose (,
non-depleted cells; , depleted cells). Cells were pulse-labeled and pro-
cessedasdescribedunder “Experimental Procedures.”OmpAsecretion/proc-
essing is affected upon SecE-depletion. C, proteinase K accessibility of MalF
(top) and OmpA/bandX (bottom) in BA13 and DO251 (SecA depletion strain
andcontrol) spheroplasts,made fromcells culturedat 41 °C (, non-depleted
cells;, depleted cells). Cells were pulse-labeled and processed as described
under “Experimental Procedures.” OmpA secretion/processing is affected
upon SecA-depletion. D, proteinase K accessibility of MalF (top) and OmpA/
bandX (bottom) in KN370/KN370 harboring pH (SecG deletion strain, pH
plasmid expressing SecG) spheroplasts. Cells were pulse-labeled and pro-
cessedasdescribedunder “Experimental Procedures.”OmpAsecretion/proc-
essingwas not affected in the absence of SecG. E, proteinase K accessibility of
MalF (top) and OmpA/bandX (bottom) in FTL10 (YidC depletion strain)
spheroplasts, made from cells cultured in the presence/absence of arabinose
(, non-depleted cells;, depleted cells). Cells were pulse-labeled and pro-
cessedasdescribedunder “Experimental Procedures.”OmpAsecretion/proc-
essing was not affected upon YidC depletion. MalF bands were quantified,
and the band volumes of spheroplasts made of control cells not treated with
proteinase K were set to 100%.
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ylated (Fig. 5). This indicates that translocation of the periplas-
mic loop between TM3 and -4 proceeds normally in the
absence of YidC in a co-translationalmechanism. To verify that
the cellswere efficiently depleted of YidC, the sampleswere also
subjected to immunoblotting using YidC-specific antibodies
(data not shown). Furthermore, to confirm that MalF-PSBT-I
and -L were synthesized at comparable levels, the blots were
also decorated with MalF antiserum (data not shown). Taken
together, these experiments suggest that YidC is not required
for the insertion of MalF into the inner membrane.
YidC Depletion Leads to Reduced Accumulation Levels of the
MalFGK2 Maltose Transport Complex—Although the inser-
tion of MalF in the inner membrane is YidC-independent, the
close proximity of different regions of nascent MalF to YidC
during insertion points to an important role of YidC in the
biogenesis of MalF. Therefore, as a next step in the character-
ization of the role of YidC in the biogenesis of MalF, the accu-
mulation levels of endogenously expressed MalFGK2 maltose
transport complex in inner membranes isolated from cells
depleted of YidC and control cells weremonitored. To this end,
membrane complexes were separated by blue native-PAGE,
and proteins were subsequently transferred to a polyvinylidene
difluoride membrane. Membranes were decorated with anti-
bodies to themaltose transport complex componentsMalF, -K,
and -G and to the translocon components YidC and SecY (Fig.
6). Strikingly, accumulation of the maltose transport complex
was strongly reduced upon YidC depletion (80% down). In
contrast, complex formation of the SecYEG-hetrotrimer was
hardly affected (5% down). This shows that YidC is involved
in the biogenesis of the maltose transport complex, that this
effect is not general, and that the reduced maltose transport
complex levels are not due to reduced Sec translocon levels.
YidC Is Required for the Stability ofMalF—Subsequently, the
steady-state level of endogenously expressed MalF in the inner
membrane of cells depleted of YidC and control cells was mon-
itored by immunoblotting. Upon YidC depletion, the accumu-
lation level of full-length MalF was strongly reduced, and two
putative MalF degradation products appeared (Fig. 7A). YidC
depletion did not affect the level of MalG, whereas the level of
MalK attached to themembrane and inwhole cells was affected
(70% down) upon YidC depletion (Fig. 7A).
The immunoblotting experiments could mean that YidC is
required for the stability of MalF. To monitor the stability of
MalF upon YidC depletion in more detail, a pulse-chase
approach was used. Cells depleted of YidC and control cells
were cultured and labeled with [35S]methionine as described
under “Experimental Procedures.” After chases of 3, 30, and 60
min, MalF was isolated by means of immunoprecipitation, and
precipitatedmaterial was subsequently analyzed by SDS-PAGE
and phosphorimaging (Fig. 7B). After a chase of 3 min, the
amount of MalF was similar in cells expressing and depleted of
YidC. However, in cells depleted of YidC the MalF signal
strongly decreased in time, whereas it remained stable in the
control cells. Because the level ofMalK in cells depleted of YidC
was lower than in wild-type cells, MalF stability was also mon-
itored in cells not expressing its complex partners MalK and
MalG (Fig. 7B). In both malK and malG deletion strains MalF
stability was not affected, which is in keeping with observations
made by Traxler and Beckwith (22). This indicates that YidC is
important for MalF stability rather than its complex partners
MalF and MalG.
DISCUSSION
So far, the role of YidC in the folding of complex membrane
proteins has only been studied in detail for the monomeric
membrane protein lactose permease (LacY). It was shown,
FIGURE 5. MalF-PBST I and MalF-PBST L (see Fig. 1) were expressed in
FTL10malF::Tn10 (pASK-IBAlacI) growneither in thepresence (YidC) or
absence (YidC) of arabinose. Anhydrotetracycline was either added to a
final concentration of 0.2g/ml or excluded from themedium. Sampleswere
collected and processed for SDS-PAGE and Western blotting as described
under “Experimental Procedures.” Streptavidin-horseradish peroxidase con-
jugate was used for detection of biotinylated proteins. The arrowhead indi-
cates theposition ofMalF-PBST L ongel. Biotin carboxyl carrier protein (BCCP)
was detected in all samples and was used as a loading control.
FIGURE 6. Reduced accumulation levels of the MalFGK2 maltose trans-
port complex upon YidC depletion.MC4100ara and FTL10 cells were cul-
tured in LB medium in the presence of maltose. Complexes in purified inner
membranes were separated by blue native-PAGE, and proteins were subse-
quently transferred to apolyvinylidenedifluoridemembrane. Blotswere dec-
orated with antibodies to YidC, SecY, and the maltose transport complex
components MalF, -K, and -G. MalFGK2, YidC, and SecYEG bands were quan-
tified, and the band volumes of purified membranes of control cells were set
to 100%. The numbers represent the intensities upon YidC depletion.
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using in vitro reconstitution approaches and a folding assay
based on monoclonal antibodies against conformational
epitopes of LacY, that YidC is required for the co-translational
folding of LacY (16). As a consequence, the stability of LacYwas
affected upon YidC depletion (16). Here, we have studied the
role of YidC in the folding of a polytopic inner membrane pro-
tein that is part of a hetero-oligomeric complex. Using a com-
bination of an in vitro cross-linking approach, in vivo biogenesis
assays, and blue native-PAGE we have monitored the role of
YidC at different stages in the biogenesis of MalF, which is a
constituent of the MalFGK2 maltose transport complex. First
however, we re-evaluated the SRP/Sec dependence of MalF,
because not all studies on its SRP/Sec dependence were
conclusive.
Targeting of MalF via the SRP pathway had been studied
before using genetic approaches. In the Slo (synthetic lethality
upon overexpression) screen, which was developed by Bern-
stein and co-workers (49), MalF was not identified as an SRP
substrate. Furthermore, blocking of the SRP-targeting pathway
by overexpression of a non-functional variant of the SRP-recep-
tor FtsY only marginally affected the insertion of a MalF alka-
line phosphatase fusion protein (49). However, in a genetic
screen designed to isolate E. colimutants affected inmembrane
protein assembly, a strain with amutation in the ffs gene, which
encodes the SRP component 4.5 S RNA, was isolated that
affected the targeting of aMalF LacZ fusion protein (47). In the
present studywe show that Ffh, a component of the SRP, can be
readily cross-linked to TM1 of nascent MalF in vitro and that
the in vivo targeting of full-lengthMalF is strongly hampered in
cells depleted of the SRP component 4.5 S RNA. It should be
mentioned that the observed cross-linking to Ffh is highly sig-
nificant considering the extremely low abundance of Ffh in
wild-type cells and hence in the translation lysate used in this
assay (50). This strongly suggests that, at least a considerable
fraction of, MalF is targeted to the inner membrane via the SRP
pathway. In short MalF nascent chains, TM1 not only interacts
with Ffh, but also with the ribosomal protein L23, which is
located near the exit of the ribosomal tunnel, and the chaperone
TF (37). SRP and the chaperone TF bind simultaneously to L23
(51, 52). TF generically binds nascent peptides exiting the ribo-
some (53). Neither TF depletion nor overproduction has any
notable effect on MalF membrane targeting/insertion.6 This is
in keeping with the notions that TF and SRP sample nascent
chains on the ribosome in a nonexclusive fashion, and that
binding of the SRP receptor, FtsY, to ribosome-bound SRP
excludes TF from the ribosome allowing the docking of the
ribosome to the Sec translocon (51).
Most SRP-dependent proteins studied thus far are targeted
to the Sec translocon in the inner membrane (1, 3). Indeed, by
means of in vitro cross-linking using MalF nascent chains of
different length, we showed that the first three TMs of MalF
insert and remain in the vicinity of the Sec translocon core
components SecY and SecE during the biogenesis of MalF.
Consistently, in vivo assembly of MalF is affected upon SecE
depletion (our data and Ref. 45). This is also in keeping with the
observation that the membrane insertion of a MalF alkaline
phosphatase fusion is affected in a strain with a mutation in
SecY that specifically affects the biogenesis of inner membrane
proteins (45, 54). In a SecG null mutant background there was
no effect on the insertion of MalF into the membrane.
Thus far, azide, an inhibitor of SecA, has been used to show
that SecA is involved in the biogenesis ofMalF (45). To examine
the involvement of SecA in the biogenesis of MalF more
directly, wemonitored the assembly ofMalF in a SecA deple-
tion strain. Upon depletion of SecA, which does not affect
the rest of the Sec translocon (46), insertion of MalF into the
inner membrane was strongly hampered. Taken together,
biogenesis of MalF appears to be SRP/SecAYE-dependent.
Using two different assays, it was shown here that in vivo
insertion and topogenesis ofMalF into themembrane were not
affected upon YidC depletion. However, in vitro cross-linking
experiments demonstrated that the first three TMs ofMalF not
only insert into the membrane close to SecY and SecE but also
to YidC. Notably, they remain in this environment at least until
the first three TMs ofMalF have emerged from the ribosome in
the co-translational insertion process. Correspondingly, it has
been shown that the first TMs of the nascent polytopic inner
membrane protein MtlA assemble simultaneously at the Sec/
YidC insertion site (15). Recently, docking of the projection
maps of YidC and the SecYEG translocon generated a potential
contiguous pathway for translocating TMs (55). This pathway
could provide an environment for the TMs where their folding
and assembly can occur prior to their release into the lipid
bilayer. The integration of aquaporin-4 into the endoplasmic
6 S. Wagner, O. Pop, G.-J. Haan, L. Baars, G. Koningstein, M. M. Klepsch, P.
Genevaux, J. Luirink, and J.-W. de Gier, unpublished results.
FIGURE 7. YidC is required for the stability of MalF. A, MC4100ara and
FTL10 cells were cultured in LB medium in the presence of maltose. Inner
membranes were isolated and analyzed by SDS-PAGE and immunoblotting
with antibodies directed against YidC,MalK, -F, and -G. Theband in theMalG
blot that ismarkedwith anasterisk is abackgroundband,which indicates that
equal amounts of membranes were loaded. B, MC4100ara, FTL10,
SW1242(malG), and SW1282(malK) cells were cultured in LB medium in
thepresenceofmaltose and labeledwith [35S]methionine asdescribedunder
“Experimental Procedures.” 3, 30, and 60 min after an excess of cold methio-
nine was added to the cultures, cells were precipitated with trichloroacetic
acid, andMalF was subsequently isolated by immunoprecipitation. Immuno-
precipitations were analyzed by SDS-PAGE and phosphorimaging (upper
panel). Relative band volumes are shown in the graph in the lower panel.
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reticulum membrane by the Sec61 translocon has been shown
to involve sequential triage of TMs from their initial portal of
entry intomultiple secondary siteswithin the translocon (56). It
was proposed that this mechanism provided a means to facili-
tate early folding events before release into the lipid bilayer. It
has been speculated that the endoplasmic reticulum-localized
TRAM protein has a similar function as YidC, and it has also
been shown that there are specialized chaperones in the endo-
plasmic reticulum mediating the co-translational folding of
specific membrane proteins (57–59).
In contrast to the TMs of MalF, MtlA, and aquaporin-4, the
twoTMs of the innermembrane protein leader peptidase (Lep)
partition one by one into the lipid bilayer via the Sec/YidC
interface according to the linear insertionmodel of TMs (41). A
possible explanation for this discrepancy may relate to the role
of the TMs in the respective proteins. The TMs of Lep merely
act as amembrane anchor for the periplasmic P2 domain of Lep
to which the catalytic activity of Lep is confined, whereas the
TMs of MtlA, MalF, and aquaporin-4 play key roles in the
functioning of these proteins. Proper folding and interaction of
theTMsofMalF,MtlA, and aquaporin-4 is an absolute require-
ment for the functioning of these proteins and may also be a
prerequisite for complex formation.
The cross-linking data are consistent with the notion that
YidC functions in co-translational folding of complex inner
membrane proteins. The importance of YidC in membrane
protein folding and assembly is also suggested by the observa-
tion that YidC depletion leads to the induction of Cpx and E
envelope stress responses that sense protein abnormalities in
the inner and outer membranes as well as in the periplasm (17,
18). Misfolding or misassembly of membrane proteins is often
linked to decreased stability (60). Although MalF was rapidly
degraded upon YidC depletion, the absence of the other con-
stituents of theMalFGK2 complex did not affect the stability of
the protein as judged by pulse-chase analysis. However, trypsin
accessibility experiments showed that the folding of the large
periplasmic loop of MalF is not completed before it is incorpo-
rated into the MalFGK2 complex (22).6 Possibly, YidC mainly
chaperones the initial folding of MalF by acting on its integral
membrane part, which is likely to be critical for MalF stability
and hence for assembly of MalFGK2 complexes.
In themal operon, the gene encodingMalG is located down-
streamof the gene encodingMalF; i.e.MalG is synthesized after
MalF and most likely will insert after MalF into the membrane.
It is tempting to speculate that MalF is kept by YidC in a con-
formation that allows a smooth MalF-MalG complex forma-
tion. However, we did not manage to isolate Sec/YidC-MalF
complexes (results not shown). In contrast, the YidC homolog
in the thylakoidal membrane, Albino3, could be isolated in a
complex within the membrane-inserted D1 protein, before it
was incorporated into the photosystem II complex (61). The
Sec and/or YidC-MalF complexes, if they indeed exist, may be
too fragile or transient to purify.
Summarizing, we have shown that the polytopic integral
membrane protein MalF, which is a constituent of the
MalFGK2 complex, is targeted to the inner membrane via the
SRP pathway to the Sec/YidC insertion site. Despite close prox-
imity of nascent MalF to YidC during insertion, YidC is not
required for the insertion of MalF into the membrane. How-
ever, YidC is required for the stability of MalF and the forma-
tion of theMalFGK2maltose transport complex. Our data indi-
cate that YidC supports the folding of MalF into a stable
conformation before it is incorporated into the maltose trans-
port complex.
Acknowledgments—We thank Jon Beckwith, Richard Brimacombe,
AmyDavidson, Frank Sargent, and Josef Brunner for strains, sera, and
reagents. We thank W. S. P. Jong for useful comments during prepa-
ration of the manuscript. Research in the laboratory of J. W. de Gier is
supported by the Swedish Research Council, the Swedish Foundation
for Strategic Research, and the Marcus and Marianne Wallenberg
Foundation.
REFERENCES
1. Luirink, J., vonHeijne, G., Houben, E., and deGier, J.W. (2005)Annu. Rev.
Microbiol. 59, 329–355
2. Luirink, J., and Sinning, I. (2004) Biochim. Biophys. Acta 1694, 17–35
3. Facey, S. J., and Kuhn, A. (2004) Biochim. Biophys. Acta 1694, 55–66
4. Van den Berg, B., Clemons,W.M., Jr., Collinson, I., Modis, Y., Hartmann,
E., Harrison, S. C., and Rapoport, T. A. (2004) Nature 427, 36–44
5. Veenendaal, A. K., van der Does, C., and Driessen, A. J. (2004) Biochim.
Biophys. Acta 1694, 81–95
6. Rapoport, T. A. (2007) Nature 450, 663–669
7. Osborne, A. R., Rapoport, T. A., and van den Berg, B. (2005) Annu. Rev.
Cell Dev. Biol. 21, 529–550
8. Clemons, W. M., Jr., Menetret, J. F., Akey, C. W., and Rapoport, T. A.
(2004) Curr. Opin. Struct. Biol. 14, 390–396
9. Dalbey, R. E., and Chen, M. (2004) Biochim. Biophys. Acta 1694, 37–53
10. Kiefer, D., and Kuhn, A. (2007) Int. Rev. Cytol. 259, 113–138
11. Xie, K., and Dalbey, R. E. (2008) Nat. Rev. Microbiol. 6, 234–244
12. Houben, E. N., Scotti, P. A., Valent, Q. A., Brunner, J., de Gier, J. L.,
Oudega, B., and Luirink, J. (2000) FEBS Lett. 476, 229–233
13. Urbanus, M. L., Scotti, P. A., Froderberg, L., Saaf, A., de Gier, J. W., Brun-
ner, J., Samuelson, J. C., Dalbey, R. E., Oudega, B., and Luirink, J. (2001)
EMBO Rep. 2, 524–529
14. Scotti, P. A., Urbanus,M. L., Brunner, J., de Gier, J.W., vonHeijne, G., van
der Does, C., Driessen, A. J., Oudega, B., and Luirink, J. (2000) EMBO J. 19,
542–549
15. Beck, K., Eisner, G., Trescher, D., Dalbey, R. E., Brunner, J., andMu¨ller, M.
(2001) EMBO Rep. 2, 709–714
16. Nagamori, S., Smirnova, I. N., and Kaback, H. R. (2004) J. Cell Biol. 165,
53–62
17. Shimohata, N., Chiba, S., Saikawa, N., Ito, K., and Akiyama, Y. (2002)
Genes Cells 7, 653–662
18. Shimohata, N., Nagamori, S., Akiyama, Y., Kaback, H. R., and Ito, K. (2007)
J. Cell Biol. 176, 307–317
19. Ehrmann, M., Ehrle, R., Hofmann, E., Boos, W., and Schlosser, A. (1998)
Mol. Microbiol. 29, 685–694
20. Oldham, M. L., Khare, D., Quiocho, F. A., Davidson, A. L., and Chen, J.
(2007) Nature 450, 515–521
21. Froshauer, S., Green, G. N., Boyd, D., McGovern, K., and Beckwith, J.
(1988) J. Mol. Biol. 200, 501–511
22. Traxler, B., and Beckwith, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,
10852–10856
23. Mourez, M., Hofnung, M., and Dassa, E. (1997) EMBO J. 16, 3066–3077
24. Froderberg, L., Houben, E., Samuelson, J. C., Chen, M. Y., Park, S. K.,
Phillips, G. J., Dalbey, R., Luirink, J., and de Gier, J. W. L. (2003) Mol.
Microbiol. 47, 1015–1027
25. Hatzixanthis, K., Palmer, T., and Sargent, F. (2003) Mol. Microbiol. 49,
1377–1390
26. Guzman, L.M., Belin, D., Carson,M. J., and Beckwith, J. (1995) J. Bacteriol.
177, 4121–4130
27. Hashemzadeh-Bonehi, L., Mehraein-Ghomi, F., Mitsopoulos, C., Jacob,
Biogenesis of MalF andMalFGK2 in E. coli Requires YidC
JUNE 27, 2008•VOLUME 283•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 17889
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
J. P., Hennessey, E. S., and Broome-Smith, J. K. (1998)Mol. Microbiol. 30,
676–678
28. Jander, G., Cronan, J. E., and Beckwith, J. (1996) J. Bacteriol. 178,
3049–3058
29. Wagner, S., Baars, L., Ytterberg, A. J., Klussmeier, A.,Wagner, C. S., Nord,
O., Nygren, P. A., van Wijk, K. J., and de Gier, J. W. (2007) Mol. Cell
Proteomics 6, 1527–1550
30. Schagger, H., and von Jagow, G. (1991) Anal. Biochem. 199, 223–231
31. Datsenko, K. A., andWanner, B. L. (2000) Proc. Natl. Acad. Sci. U. S. A. 97,
6640–6645
32. Miller, J. H. (1992) A Short Course in Bacterial Genetics, Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY
33. Houben, E. N., Zarivach, R., Oudega, B., and Luirink, J. (2005) J. Cell Biol.
170, 27–35
34. Ullers, R. S., Houben, E. N., Raine, A., ten Hagen-Jongman, C. M., Ehren-
berg, M., Brunner, J., Oudega, B., Harms, N., and Luirink, J. (2003) J. Cell
Biol. 161, 679–684
35. de Gier, J. W., and Luirink, J. (2003) EMBO Rep. 4, 939–943
36. Ferbitz, L., Maier, T., Patzelt, H., Bukau, B., Deuerling, E., and Ban, N.
(2004) Nature 431, 590–596
37. Ban, N., Nissen, P., Hansen, J.,Moore, P. B., and Steitz, T. A. (2000) Science
289, 905–920
38. Gu, S. Q., Peske, F., Wieden, H. J., Rodnina, M. V., and Wintermeyer, W.
(2003) RNA (N. Y.) 9, 566–573
39. Kramer, G., Rauch, T., Rist, W., Vorderwulbecke, S., Patzelt, H., Schulze-
Specking, A., Ban, N., Deuerling, E., and Bukau, B. (2002) Nature 419,
171–174
40. Halic,M., Gartmann,M., Schlenker, O.,Mielke, T., Pool,M. R., Sinning, I.,
and Beckmann, R. (2006) Science 312, 745–747
41. Houben, E. N., ten Hagen-Jongman, C. M., Brunner, J., Oudega, B., and
Luirink, J. (2004) EMBO Rep. 5, 970–975
42. de Gier, J.-W. L., Mansournia, P., Valent, Q., Phillips, G. J., Luirink, J., and
von Heijne, G. (1996) FEBS Lett. 399, 307–309
43. Ribes, V., Romisch, K., Giner, A., Dobberstein, B., and Tollervey, D. (1990)
Cell 63, 591–600
44. Akiyama, Y., Kihara, A., Tokuda, H., and Ito, K. (1996) J. Biol. Chem. 271,
31196–31201
45. Traxler, B., and Murphy, C. (1996) J. Biol. Chem. 271, 12394–12400
46. Qi, H. Y., and Bernstein, H. D. (1999) J. Biol. Chem. 274, 8993–8997
47. Tian,H., Boyd, D., and Beckwith, J. (2000)Proc. Natl. Acad. Sci. U. S. A. 97,
4730–4735
48. Tian, H., and Beckwith, J. (2002) J. Bacteriol. 184, 111–118
49. Ulbrandt, N. D., Newitt, J. A., and Bernstein, H. D. (1997)Cell 88, 187–196
50. Adams, H., Scotti, P. A., de Cock, H., Luirink, J., and Tommassen, J. (2002)
Eur. J. Biochem. 269, 5564–5571
51. Buskiewicz, I., Deuerling, E., Gu, S. Q., Jockel, J., Rodnina,M. V., Bukau, B.,
and Wintermeyer, W. (2004) Proc. Natl. Acad. Sci. U. S. A. 101,
7902–7906
52. Raine, A., Ivanova, N., Wikberg, J. E., and Ehrenberg, M. (2004) Biochimie
(Paris) 86, 495–500
53. Patzelt, H., Rudiger, S., Brehmer, D., Kramer, G., Vorderwulbecke, S.,
Schaffitzel, E., Waitz, A., Hesterkamp, T., Dong, L., Schneider-Mergener,
J., Bukau, B., and Deuerling, E. (2001) Proc. Natl. Acad. Sci. U. S. A. 98,
14244–14249
54. Newitt, J. A., and Bernstein, H. D. (1998) J. Biol. Chem. 273, 12451–12456
55. Lotz, M., Haase, W., Kuhlbrandt, W., and Collinson, I. (2008) J. Mol. Biol.
375, 901–907
56. Sadlish, H., Pitonzo, D., Johnson, A. E., and Skach, W. R. (2005) Nat.
Struct. Mol. Biol. 12, 870–878
57. Johnson, A. E., and van Waes, M. A. (1999) Annu. Rev. Cell Dev. Biol. 15,
799–842
58. Kota, J., and Ljungdahl, P. O. (2005) J. Cell Biol. 168, 79–88
59. Kota, J., Gilstring, C. F., and Ljungdahl, P. O. (2007) J. Cell Biol. 176,
617–628
60. Ito, K., and Akiyama, Y. (2005) Annu. Rev. Microbiol. 59, 211–231
61. Ossenbuhl, F., Gohre, V., Meurer, J., Krieger-Liszkay, A., Rochaix, J. D.,
and Eichacker, L. A. (2004) Plant Cell 16, 1790–1800
Biogenesis of MalF andMalFGK2 in E. coli Requires YidC
17890 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 26•JUNE 27, 2008
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
VOLUME 284 (2009) PAGES 30547–30555
DOI 10.1074/jbc.A109.040964
Dual activities of odorants on olfactory and nuclear
hormone receptors.
Horst Pick, Sylvain Etter, Olivia Baud, Ralf Schmauder, Lorenza Bordoli,
Torsten Schwede, and Horst Vogel
On page 30551, Table 1, first column, the experimentally determined
values of EC50 of ER activation for MC, Polysantol, Javanol, and andro-
stenol have been presented with the wrong concentration (mM). The
correct concentration is M.
VOLUME 283 (2008) PAGES 36211–36220
DOI 10.1074/jbc.A806576200
TRAF6 andMEKK1 play a pivotal role in the RIG-I-like
helicase antiviral pathway.
Ryoko Yoshida, Giichi Takaesu, Hideyuki Yoshida, Fuyuki Okamoto,
Tomoko Yoshioka, Yongwon Choi, Shizuo Akira, Taro Kawai,
Akihiko Yoshimura, and Takashi Kobayashi
On page 36212, the sequences of PCR primers of IFN- are incorrect.
Thecorrect sequences are as follows: IFN-, 5-ATGGCTAGGCTCTGT-
GCTTTCCT-3 and 5-AGGGCTCTCCAGACTTCTGCTCTG-3.
VOLUME 283 (2008) PAGES 7470–7479
DOI 10.1074/jbc.A707758200
Lysophosphatidic acid receptor-dependent secondary
effects via astrocytes promote neuronal differentiation.
Taˆnia Cristina de Sampaio e Spohr, Ji Woong Choi, Shannon E. Gardell,
Deron R. Herr, Stevens Kastrup Rehen, Fla´via Carvalho Alcantara Gomes,
and Jerold Chun
The first author in the PubMed citation should be listed as Spohr,
T. C. S.
VOLUME 283 (2008) PAGES 17881–17890
DOI 10.1074/jbc.A801481200
Biogenesis of MalF and theMalFGK2maltose transport
complex in Escherichia coli requires YidC.
Samuel Wagner, Ovidiu Ioan Pop, Gert-Jan Haan, Louise Baars,
Gregory Koningstein, MirjamM. Klepsch, Pierre Genevaux, Joen Luirink,
and Jan-Willem de Gier
Dr. Pop’s first name was misspelled. His correct name is shown above.
VOLUME 284 (2009) PAGES 11425–11435
DOI 10.1074/jbc.A806395200
MEK1 binds directly to arrestin1, influencing both its
phosphorylation by ERK and the timing of its
isoprenaline-stimulated internalization.
DongMeng, Martin J. Lynch, Elaine Huston, Michael Beyermann, Jenny
Eichhorst, David R. Adams, Enno Klussmann, Miles D. Houslay,
and George S. Baillie
Dr. Klussmann’s name was misspelled. The correct spelling is shown
above.
TABLE 1
Estrogenic activities of odorants
The compound concentrations (EC50) evoking half-maximal estrogenic activity in
transcription activation, the dissociation inhibition constants (Ki) calculated from
the IC50 values of the ES2 displacement curves (Fig. 1), and the corresponding Ki
values calculated using the 6D-QSAR model are compared. For Polysantol and
Javanol, only the Ki values for the energetically most favorable conformation are
reported. The IC50 values for the remaining stereoisomers are as follows: 140 173
MPolysantol (S,S), 216 122MPolysantol (S,R), 2.86 4.45mMPolysantol (R,R),
2.41 2.64 mM Javanol (R,S), 176.7 567 M Javanol (S,S), and 40.73 23.33 M
Javanol (S,R). The Ki values for the remaining stereoisomeric forms are as follows:
299 M Polysantol (S,S), 83 M Polysantol (S,R), 1 mM Polysantol (R,R), 931 M
Javanol (R,S), 68 M Javanol (S,S), and 15 M Javanol (S,R).
Compound EC50 of ERactivation
Ki of ER
competitive binding
Ki of ER
predicted
Estradiol 0.16 0.01 nM 1.6 1 nM 2 nM
MC 86 8 M 76 6 M 21 M
Polysantol (R,S)a 98 23 M 56 5 M 26 M
Javanol (R,R)a 50 4 M ca. 50 M 5 M
Androstenol 52 3 M ca. 25 M 10 M
a The indicated stereoisomers were used for predicting Ki values, whereas experi-
ments were performed using mixtures of stereoisomers.
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